COVID-19 spurred a medtech M&A boom this summer. Will it last?

Siemens Healthineers' CEO was rebuffed by his counterpart at Varian in January. But come May, the impact of coronavirus began to become clear. 

By Nick Paul Taylor • Sept. 30, 2020

Smith & Nephew inks $240M deal to buy orthopaedic assets from Integra

The U.K.-based medtech will gain control of a portfolio of shoulder replacement products and other devices that generated revenues of $90 million last year.

By Nick Paul Taylor • Sept. 29, 2020

Illumina inks $8B Grail buyout for liquid biopsy market. Investors are not sold.

Shares in Illumina, which formed cancer detection startup Grail in 2016, fell as analysts questioned whether the cash-and-stock deal plays to its strengths.

By Nick Paul Taylor , Greg Slabodkin • Sept. 21, 2020

Qiagen completes takeover of PCR automation player NeuMoDx for $248M

The still-independent Dutch molecular diagnostics company said NeuMoDx devices process test results three times as fast as some rival systems.

By Nick Paul Taylor • Sept. 18, 2020

Intersect ENT strikes €60 Fiagon buyout to expand in balloon sinuplasty

The takeover of the German electromagnetic surgical navigation specialist comes two months after a report that Medtronic moved to acquire Intersect.

By Nick Paul Taylor • Sept. 16, 2020

Stryker reaches agreement with Colfax for Wright Medical deal divestitures

The medtech disclosed Thursday the orthopaedics competitor's DJO Global subsidiary agreed to acquire its ankle and finger joint replacement businesses to shore up U.S. and U.K. antitrust concerns.

By Maria Rachal • Updated Oct. 16, 2020

Stryker stretches Wright Medical share offer into Q4

As the medtech makes the fifth offer extension since the $4 billion acquisition was announced last November, the company is approaching the latest time it said the deal would close.

By Susan Kelly • Updated Sept. 29, 2020

Philips pens $275M Intact Vascular deal to acquire implant

The buy adds the first FDA-approved vascular implant for below-the-knee interventions to the Dutch conglomerate's portfolio.

By Nick Paul Taylor • Aug. 28, 2020

Hologic inks $80M Acessa buyout to expand women's health business

The cash acquisition, plus contingent payments based on future revenue growth, will add a treatment for benign uterine fibroid to the medtech's portfolio.

By Nick Paul Taylor • Aug. 26, 2020

IDx rebrands, buys 3Derm to expand automated AI portfolio

The takeover gives the company, now known as Digital Diagnostics, control of two breakthrough device-designated autonomous artificial intelligence systems.

By Nick Paul Taylor • Aug. 20, 2020

Medtronic seeks leg up in lagging pen market with Companion Medical buy

As Dexcom and Abbott grow share in the continuous glucose monitoring market and Insulet and Tandem forge on with interoperable insulin pump systems, Medtronic is hoping to jump ahead with a connected pen.

By Maria Rachal • Aug. 17, 2020

Thermo Fisher-Qiagen deal falls apart after failing to secure shareholder support

Thermo Fisher recently raised its bid for Qiagen shares, taking into account the company's COVID-19 testing gains. But when the offer expired Monday, less than half of shares were tendered.

By Nick Paul Taylor , Maria Rachal , Greg Slabodkin • Updated Aug. 13, 2020

Livongo scooped up by Teladoc in $18.5B deal

An explosion in the use of virtual care during the pandemic may have sped up the timeline for the merger. Both companies' share prices are down on the news.

By Shannon Muchmore • Updated Aug. 5, 2020

Americas drag on Qiagen as Thermo Fisher deal goes down to the wire

A hedge fund that owns 8% of Qiagen "fully" expects the Thermo Fisher offer to fail, calling it “wholly inadequate.”

By Nick Paul Taylor • Aug. 5, 2020

Varian sold to Siemens Healthineers in $16.4B all-cash deal

Breaking with a trend of smaller medtech deal values in 2020, the pact will see radiation oncology equipment and software maker Varian Medical Systems operate as an independent company under Siemens Healthineers.

By Maria Rachal • Updated Aug. 3, 2020

Coronavirus could fuel clinical lab M&A by stressing smaller hospital players

Consultancy Kaufman Hall predicts a ramp-up of deals throughout the year, as hospital-owned labs seek support amid the pandemic. That forecast meshes with comments from Quest's CEO last week.

By Nick Paul Taylor • July 29, 2020

Medical device deal values down 88% amid COVID-19 disruption: PwC

Going forward, M&A may rise in light of recent deferral of elective procedures, which analysts say “could create the need for significant consolidation as companies work to remain competitive.”  

By Nick Paul Taylor • July 23, 2020

Thermo Fisher ups Qiagen offer by 10% after investor backlash cites COVID-19 growth

The acquisition was announced weeks before the U.S. doubled down on its need for widespread coronavirus testing, which provided a big business opportunity for Qiagen that it capitalized on during the second quarter.

By Maria Rachal • July 16, 2020

Medtronic closes Medicrea buyout, seeking spinal surgery boost

Four months after announcing the deal for the French medtech, Medtronic also highlighted its expanding foothold in AI, machine learning and predictive analytics. 

By Maria Rachal • Updated Nov. 16, 2020

UK signals Stryker offer to unload ankle replacement product could clear Wright Medical buy

The medtech giant's proposed $4 billion acquisition prompted competition concerns among regulators. Stryker disclosed in a filing Wednesday it pitched divesting its STAR product line, which may satisfy U.K. authorities.

By Greg Slabodkin • July 15, 2020

Shareholder challenges Thermo Fisher's $11.5B deal to buy Qiagen

COVID-19 has made "significantly clearer" the importance of Qiagen's testing business, according to investment management firm Davidson Kempner, which is urging other shareholders to reject the offer priced in early March.

By Susan Kelly • July 13, 2020

Intersect ENT stock jumps on report of potential Medtronic takeover

A Bloomberg report published late Tuesday said the medtech giant had made an offer for the sinusitis tech maker, citing people with knowledge of the matter. Shares in Intersect were up around 35% early Wednesday.

By Maria Rachal • July 8, 2020

UK raises red flags about Stryker's $4B bid for Wright Medical

The Competition and Markets Authority suggested the proposed acquisition would result in Stryker controlling 90% of Britain's total ankle replacement prostheses market.

By Greg Slabodkin • July 1, 2020

Invitae cash-and-stock buyout of ArcherDX a done deal

The medical genetic testing company swept in after the assay developer announced plans to go public. Invitae will now offer tests for more stages of cancer care, from assessing disease risk to monitoring its progression.

By Maria Rachal • Updated Oct. 5, 2020

Medtronic, Titan Medical ink robotics development, license agreements

The beleaguered robotic surgery company said Thursday it will receive up to $31 million from Medtronic's licensing of technologies. It's the medtech giant's second robotics deal this year as it works to launch its own soft tissue robot.   

By Greg Slabodkin • June 4, 2020